Download Technology Capabilities
250+ highly skilled employees in multidisciplinary teams
Offices in Germany, India, USA
20+ global clients including many Big Pharma
in Data Protection ISO/IEC 27001:2013 Certification
machine learning & AI framework & blockchain technology
300TB+, adding more each week
100+ patent applications including 23 grants
Cutting edge technology to build reliable, secure & compliant applications
“Our Vision is to be recognized by our customers as leading provider of Artificial Intelligence based products offering best in class data crawling, aggregation, analysis and visualization solutions.”
“We enable customers to succeed in a competitive market by delivering real time access to the full picture of relevant data.
We continuously develop our products based on Artificial Intelligence to enable broader, deeper and faster insights and to enable more informed decision making.”
CHAIRMAN, SUPERVISORY BOARD
Dr. Andreas Penk is the President, Pfizer Pharmaceuticals Group China, since 2019. He has led the Pfizer, China during COVID-19 outbreak securing full operability and fast return to business. He has also been former Regional President (Oncology) for international developed markets (50+ countries) and former Country Manager, Germany. During this tenure, he has launched Breast Cancer treatment IBRANCE – the best launch ever in oncology in the region establishing a new benchmark in the industry.
Dr. Penk has held multiple senior positions such as Former Vice-Chairman, German Research Based Pharmaceutical Industry Association (VfA) , Former member, Executive Committee – European Federation Of Pharmaceutical Industries and Associations, Member of the Board of Trustees, Robert Koch Foundation and more.
Dr. Penk has received M.D. from University of Leipzig, Germany.
VICE-CHAIRMAN, SUPERVISORY BOARD
Florian Rentsch is the Chairman of the Board of Directors at Verband der Sparda-Banken e.V. since 2017.
He was a member of the Hessian State Parliament from 2003-2017. He was the Minister for Economics, Transport, Urban and Regional Development in Hesse from 2012 to 2014, In this capacity, he was responsible for the Financial Centre, Frankfurt as well as stock exchange supervision.
Between 2009 and 2012 and from 2014 until May 2017, Florian Rentsch was chairman of the FDP parliamentary party in the Hessian State Parliament. His main focus was on economic and legal policies. Moreover, since 2003, Florian Rentsch has worked as a lawyer for corporate law firms in Wiesbaden and Frankfurt am Main with a focus on strategic counseling in business law, governance, compliance and labor law. He has many years of practical expertise in the areas of finance, pharmaceuticals, health, chemicals, transport and energy.
Florian Rentsch studied law in Mainz and Frankfurt am Main and is authorized to practice as a lawyer.
MEMBER, SUPERVISORY BOARD
Hans-Christian Semmler is Managing Director of Frankfurt based, technology focused, HCS Beteiligungsgesellschaft mbH, founded in 2003. Since 2014, he is also a member of the supervisory board of AGO AG Energie + Anlagen.
From 2003 to 2010, he held the position of CEO at Haupt Pharma AG, a contract manufacturer and developer of pharmaceutical products with various company sites in Europe and Japan. From 1995 to 2001, he was CFO of Vossloh AG, one of the world’s leading railway engineering companies. He was also a member of the supervisory board of VAE AG. Prior to this, he worked in investment banking in Deutsche Bank.
Hans-Christian Semmler studied law and business administration in Kiel, Vienna and Passau and is authorized to practice as a lawyer.
MEMBER, SUPERVISORY BOARD
Ruben King-Shaw Jr. has over three decades of executive leadership experience in the healthcare technology and private equity sectors and has held C-suite positions with leading private companies. He is a Chief Strategy Officer and Member of the Executive Committee of the Board of Steward Health, LLC since 2018. He is also a Chief executive officer of Mansa Equity Partners, Inc., a private equity and investment advisory firm specializing in supporting the growth of healthcare companies.
Mr. King-Shaw served on the Obama Administration’s Medicare Program Advisory and Oversight Committee. He was also the COO and Deputy Administrator of the Centers for Medicare and Medicaid Services (CMS) during the President George W. Bush administration. He was a senior advisor to the Secretary of the U.S. Treasury for health care tax policies.
He completed his Bachelor of Science degree in Industrial and Labor Relations, at Cornell University, and earned both Master of Health Service Administration and a Master of International Business degree from Florida International University. He has also completed advanced studies in Corporate Governance from the Harvard Business School.
At Innoplexus, we believe in giving back to the society by leveraging our strengths to the benefit of our local communities: sharing our knowledge, expertise and capabilities, and investing time in giving back to the communities in which we operate.
Innoplexus is guided by a deep commitment to good corporate citizenship through our employees’ donation of time and skills. We are supporting and encouraging our employees to volunteer at a wide range of organizations worldwide.
Sponsored by the company’s leadership, each and every Innoplexus employee has the opportunity to contribute their time, knowledge and skills towards community activity on a weekly, monthly and yearly basis.
Read our CSR Policy.
One of our projects is an early learning support in Pune. Innoplexus employees chose to promote excellence in education among children with emphasis on bridging gaps between various socio-economic groups towards academic and personal excellence with the long-term vision of their integration into higher education and advanced careers.
Innoplexus employees volunteer in a variety of activities to provide the children academic reinforcement and positive role modelling.
In the last couple of years, data science has continued to make rapid advances, particularly in the fields of machine learning and deep learning. It is predicted that the demand for data scientists and data engineers alone will grow by 39 percent until 2020. It is challenging to recruit people skilled at machine learning, big data, and data science, not only because of the limited talent available but also because of the rapidly evolving landscape.
Therefore, we at Innoplexus collaborate with the talents of tomorrow with an educational programme to encourage out of the box thinking. We have a cooperation with the Gymnasium Riedberg in Frankfurt, Germany. The bilingual school has a focus on natural sciences and languages. Innoplexus experts give virtual lessons in e.g. machine learning and insights into the practical application of cutting-edge AI technologies. This is a two-month programme, with 6 sessions of 1.5 hours each (total 9 hours), followed by an assignment/ minor project.
With our membership in the German Association “Bundesverband für Künstliche Intelligenz”, we support the socially responsible use of AI technologies. Promoting research, development, and the implementation of humane AI technologies as well as educating society and industries on opportunities and risks play an important role.
The KI quality seal of the KI Bundesverband e.V. pursues the goal of a people-centered and human-beneficial use of Artificial Intelligence. By defining and adhering to an overarching understanding of values and processes, the seal ensures ethical service and product development. In the center stand quality criteria ethics, impartiality, transparency, as well as security and data protection. For each quality criterion, necessary measures are to be recorded. At the time of introduction, the seal includes a self-declaration which is signed by Innoplexus.